Connect with us

Health

Mozzies may be carrying Japanese encephalitis this summer. Here’s what to know if you’re spending time outdoors

There’s no widespread dengue, yellow fever or malaria. But there are still many viruses that local mosquitoes can spread. Despite predictions of a rare mid-summer return of La Niña, there’s still speculation about what this means for temperature and rainfall. We may not see flooding, but there is still likely to be enough water around […]

Published

on

Mozzies may be carrying Japanese encephalitis this summer. Here's what to know if you're spending time outdoors

There’s no widespread dengue, yellow fever or malaria. But there are still many viruses that local mosquitoes can spread.

Despite predictions of a rare mid-summer return of La Niña, there’s still speculation about what this means for temperature and rainfall. We may not see flooding, but there is still likely to be enough water around for mosquitoes.

After its unexpected arrival, it now seems Japanese encephalitis virus is here to stay. But how this virus interacts with local mosquitoes and wildlife, under the influence of increasing unpredictable climatic conditions, requires more research.

Mosquito-borne diseases in Australia

You can get better protection by also covering up with a long-sleeved shirt, long pants, and covered shoes.

Japanese encephalitis virus was initially discovered in southeastern Australia during the summer of 2021–22, and the boom in mosquito and waterbird populations that followed flooding at the time contributed to its spread.

Meanwhile, Murray Valley encephalitis virus has been detected in sentinel chicken flocks – which health authorities use to test for increased mosquito-borne disease risk – in NSW and in the Kimberley region of Western Australia.

Some regions of Australia may have experienced flooding, but for many regions of the country, conditions have been hot and dry. This is bad news for mosquitoes.

About 5,000 cases of mosquito-borne disease are reported in Australia each year. The vast majority of these are due to Ross River virus. The disease this virus causes is not fatal, though it can be severely debilitating.

This summer, Japanese encephalitis virus has been detected in mosquitoes and feral pigs in NSW. The virus has also been detected in environmental surveillance in northern Victoria, and we know at least one person has been affected there.

In the summer of 2023–24, hot and dry summer conditions returned, mosquito numbers declined, and the number of cases of disease caused by Japanese encephalitis virus and Murray Valley encephalitis dropped.

A close-up photo of a mosquito in a laboratory.
Australian mosquitoes, such as Culex annulirostris, can play an important role in the spread of viruses.
A/Prof Cameron Webb/NSW Health Pathology

The influence of weather patterns

So why are Japanese encephalitis virus and Murray Valley encephalitis virus active again when the conditions appear to be less favourable?

Outbreaks in southeastern Australia often accompany flooding brought on by La Niña weather patterns. Floods provide ideal conditions for mosquitoes, as well as the waterbirds that harbour the virus.

The symptoms of human disease caused by these two viruses are similar.

Japanese encephalitis virus is closely related to Murray Valley encephalitis virus. Mosquitoes pick up both viruses by biting waterbirds. But Japanese encephalitis virus has only recently become widespread in Australia.

So what is Japanese encephalitis, and how can you protect yourself and your family if you live, work or are holidaying in mosquito-prone regions this summer?

It’s unusual to see activity of these viruses when conditions are relatively dry and mosquito numbers relatively low.

After flooding rains brought on by La Niña in 2020, conditions that persisted for three years, Murray Valley encephalitis virus returned and Japanese encephalitis virus arrived for the first time.

Wherever you live, mosquito bite prevention is key. Apply insect repellent when outdoors, especially during dawn and dusk when mosquitoes are most active or at any time of the day if you’re in bushland or wetland areas where numbers of mosquitoes may be high.

Additional deaths have been reported due to Murray Valley encephalitis in recent years – two each in Western Australia and the Northern Territory.

What’s different this summer?

There also isn’t any evidence of more waterbird activity. In fact, numbers have declined in recent years.

For Japanese encephalitis virus, it may be that feral pigs are playing a more important role in its spread. We know numbers are on the rise and with drier conditions, perhaps mosquitoes and feral pigs, and other wildlife, are gathering together where they can find bodies of water.

Chickens can play an important role in helping warn of an increased risk of mosquito-borne disease.

The public health alerts in Victoria and NSW focus especially on specific regions in northern Victoria and around Griffith and Narromine in NSW where the virus has been detected.

There’s no specific treatment for either disease, though there is a vaccine for Japanese encephalitis which may be appropriate for certain people at high risk (more on that later).

Most people infected show no symptoms. In mild cases, there may be fever, headache and vomiting. In more serious cases, people may experience neck stiffness, disorientation, drowsiness and seizures. Serious illness can have lifelong neurological complications and, in some cases, the disease is life-threatening.

There have been around 80 cases of disease caused by these two viruses combined over the past four years. This includes seven deaths due to Japanese encephalitis across Queensland, NSW, South Australia and Victoria.

Now both viruses appear to be back. So what’s going on?

This news comes after both Victoria and New South Wales issued public health alerts in recent weeks warning about the virus.

There is no evidence that mosquito numbers are booming like they did back when La Niña brought floods to the Murray-Darling Basin.

But there is no vaccine available for Murray Valley encephalitis or Ross River viruses.

How can you reduce your risk this summer?

Relative to other parts of the world, Australia has traditionally been very low risk for potentially life-threatening mosquito-borne diseases.

A Victorian man is reportedly in a critical condition in hospital after contracting Japanese encephalitis from a mosquito bite.

Disease caused by two other pathogens, Japanese encephalitis virus and Murray Valley encephalitis virus, are much rarer but potentially fatal.

If you live or work in areas at risk of Japanese encephalitis, seek advice from your local health authority to see if you are eligible for vaccination. Residents in specified local government areas in affected regions in both states are currently eligible for a free vaccine.

Murray Valley encephalitis virus has been known in Australia for many decades. After a significant outbreak across the Murray Darling Basin region in 1974, activity has generally been limited to northern Australia.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Illinois’ first measles case of 2025 confirmed, health officials urge vaccination

CHICAGO – Illinois health officials have confirmed the state’s first measles case of the year, but they say the risk to the public remains low. What we know: The Illinois Department of Public Health (IDPH) confirmed on Wednesday that an adult in far southern Illinois tested positive for measles—the first case reported in the state […]

Published

on

Illinois' first measles case of 2025 confirmed, health officials urge vaccination

Illinois health officials have confirmed the state’s first measles case of the year, but they say the risk to the public remains low.

What we know:

The Illinois Department of Public Health (IDPH) confirmed on Wednesday that an adult in far southern Illinois tested positive for measles—the first case reported in the state this year. The diagnosis was made through laboratory testing, and at this time, it’s not considered an outbreak.

The individual received care at a local clinic, which is working with IDPH and local health officials to identify any possible exposure. Staff at the clinic were masked and considered immune, and the clinic is reviewing the immune status of any potentially exposed patients.

The general risk of community transmission remains low, but IDPH says it will keep the public informed of any new developments.

“This first reported case of measles in Illinois in 2025 is a reminder to our Illinois residents that this disease can be prevented with up-to-date vaccination,” said IDPH Director Dr. Sameer Vohra.

What we don’t know:

IDPH has not shared additional details about the affected individual, including their age and whether it’s a man or woman.

What’s next:

People who may have been exposed—and are not immune—are advised to monitor for symptoms such as rash, high fever, cough, runny nose, or red-watery eyes.

If symptoms appear, which could take up to 21 days, residents should contact a healthcare provider before visiting a clinic or hospital to prevent potential spread.

Dig deeper:

Illinois hasn’t seen any measles cases since a 2024 outbreak in Chicago that infected 67 people.

Meanwhile, outbreaks in Texas and New Mexico have totaled over 680 confirmed cases, including three deaths, two of which were children, according to reports.

IDPH is reminding residents—especially travelers and those with unvaccinated children—to check their MMR vaccine status. Two doses are 97% effective in preventing measles, according to Dr. Vohra.

The state’s new Measles Outbreak Simulator Dashboard helps parents and schools assess vaccination coverage at individual schools, part of a broader effort to prepare for potential outbreaks.

Big picture view:

Vaccination rates have declined nationally since the COVID-19 pandemic, raising concerns among public health officials about the resurgence of preventable diseases like measles.

For more information about measles, visit the IDPH or CDC’s websites.

The Source: The information in this article was provided by the Illinois Department of Public Health.

HealthIllinoisNews
Continue Reading

Health

Dengue Outbreaks

Dengue is one of the most common vector-borne viral diseases today, with ongoing outbreaks in Asia and Latin America. Its spread to North America highlights its global significance, as climate change and global warming increase the likelihood of its expansion into previously unaffected regions. With the development and availability of new vaccines, policymakers must determine […]

Published

on

Dengue Outbreaks

Dengue is one of the most common vector-borne viral diseases today, with ongoing outbreaks in Asia and Latin America. Its spread to North America highlights its global significance, as climate change and global warming increase the likelihood of its expansion into previously unaffected regions.

With the development and availability of new vaccines, policymakers must determine which are most suitable for at-risk populations. This session, presented at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 2025 in Vienna, Austria, explored the geographic distribution, clinical presentation, treatment algorithms, and potential use of current dengue vaccines.

In Brazil, dengue follows a seasonal pattern, peaking during the rainy season from October to May. Most cases occur in adults aged 20-59 years, with deaths primarily affecting individuals with comorbidities or those older than 60 years. Since 2010, all four serotypes have been circulating, but dengue virus (DENV) serotypes 1 (DENV-1) and 2 (DENV-2) have been most common recently.

However, 2024 has seen an unprecedented epidemic in terms of both case numbers and duration. Changes in dominant serotypes are believed to contribute to the surge in infections and shifts in disease severity.

In this context, controlling the dengue epidemic means reducing infectivity and protecting vulnerable individuals. Since mosquito vector control is complex and no specific treatment for dengue exists, vaccines are the key preventive tool. Expanding vaccine availability and including travelers in the susceptible population are crucial steps.

The speaker’s team at this conference, from the Butantan Institute in São Paulo, Brazil, has been involved in the development of one of these vaccines. It is a tetravalent live-attenuated vaccine that covers all four dengue serotypes. The vaccine originated from the Laboratory of Infectious Diseases at the US National Institutes of Health, which licensed it to interested partners for further development. In 2018, Merck Sharp & Dohme Pharmaceuticals Ltd. and the Butantan Institute began a collaboration to advance the vaccine.

The ongoing phase 3 trial is a single-dose, placebo-controlled study that has enrolled more than 16,000 participants, who will be followed for a total of 5 years. The primary goal is to assess efficacy through polymerase chain reaction diagnosis of symptomatic dengue cases and to monitor for any potential vaccine-related adverse effects.

An interim analysis was conducted after 2 years of follow-up. Data are presented for DENV-1 and DENV-2, as these were the most prevalent during the latest epidemic, with no cases of DENV serotypes 3 or 4 detected during the study period.

  • When considering DENV-1 and DENV-2 together, without differentiating participants’ serological status, the vaccine’s efficacy was 79.6%. After adjusting for prior dengue infection, efficacy increased to 89.2% compared with 73.6% in seronegative individuals.
  • For DENV-1, without adjusting for serostatus, efficacy was 89.5%, reaching 96.8% in participants with prior dengue exposure and dropping to 85.6% in those without prior exposure.
  • For DENV-2, without adjusting for serostatus, efficacy was 69.6%, rising to 83.7% in participants with prior dengue exposure and falling to 57.9% in those without prior exposure.
  • Systemic adverse effects were common (58%), though severe reactions were rare. Their frequency increased with age. The most reported adverse effects included headache, rash, and itching across all age groups, while the most frequent local reaction was pain at the injection site.

One of the vaccine’s key advantages is that it requires only a single dose, making it ideal for outbreak situations and enabling a rapid response. Although it is pending approval by the Brazilian government, it is expected to begin administration this year. It will take at least 5 years to produce enough doses to vaccinate the entire country.

This story was translated from Univadis Spain using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

TOP PICKS FOR YOU

Continue Reading

Health

Track the spread of measles in Texas

Audio recording is automated for accessibility. Humans wrote and edited the story. See our AI policy, and give us feedback. Sign up for The Brief, The Texas Tribune’s daily newsletter that keeps readers up to speed on the most essential Texas news. The number of cases reported in Texas’ historic measles outbreak has risen to […]

Published

on

Track the spread of measles in Texas


What is measles? 

How do you prevent measles?  

Can you get sick if you’re vaccinated?

Has anyone died during this outbreak? 

Where else in Texas have there been measles cases this year? 

Do we know how measles arrived in Gaines County?

I thought we fixed measles. What happened? 

When was the last time Texas had a measles outbreak?

What do we know about Gaines County’s Mennonite community? 

Who is most vulnerable to measles?

How bad can measles symptoms get? 

What are state and local agencies doing to manage this? 


Continue Reading

Trending